Application Note: Testing immuno-oncology agents in organ-specific 3D cell culture models
6 January 2020

In this application note, zPREDICTA demonstrates their 3D culture services based on their tumorspecific technology, where tissue-specific extracellular matrix (ECM) and tumor-specific medium supplements provide a physiologically relevant tumor microenvironment for accurate testing of anticancer compounds.

Company